Medical News

RSS

Tactx Medical acquired by Creganna

Creganna, a leading supplier of technologies and services to medical device and lifesciences companies today announced that it has acquired Avalon Medical Services Pte Ltd. which trades as Tactx Medical Inc.

4 Jan 2010

Congressional negotiators returning to start conference talks on health reform bill

Democratic lawmakers will begin this week to try to hammer out a compromise between the House and Senate versions of a health care reform bill as they keep an eye on votes for the measures.

4 Jan 2010

Delays and denials of disability claims at VA frustrate veterans

CBS News' 60 Minutes reports on delays and wrongful denials of disability claims by the Department of Veterans Affairs. "There is a sacred tradition in the military: leave no one behind on the battlefield. But many veterans are beginning to believe their country has left them behind at home, once they're out of uniform and in need of help."

4 Jan 2010

Despite huge expansion of coverage, millions of people would remain uninsured under Senate bill

The Senate health care reform bill would leave as many as 23 million people without insurance by 2018, providing a problem for Democrats who ultimately want universal health care, The Washington Post reports.

4 Jan 2010

Scientists uncover an important link between inflammation and breast cancer stem cells

Scientists at the University of Michigan Comprehensive Cancer Center have uncovered an important link between inflammation and breast cancer stem cells that suggests a new way to target cells that are resistant to current treatments.

4 Jan 2010

BioElectronics set to market its Allay product in Chinese market

BioElectronics Corporation, the maker of inexpensive, disposable, drug-free, anti-inflammatory devices, today announces its entry into one most dynamic and fastest growing economies in the world, the People's Republic of China.

4 Jan 2010

DSPA submits lurasidone NDA to the FDA

Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.

4 Jan 2010

Discovery of key process in bacterial infection could lead to new drug targets to prevent infection

Bacteria can swim, propelling themselves through fluids using a whip-like extension called a flaggella. They can also walk, strolling along solid surfaces using little fibrous legs called pili. It is this motility that enable some pathogenic bacteria to establish the infections - such as meningitis - that cause their human hosts to get sick or even die.

4 Jan 2010

Physicians raise concerns about proposed Medicare changes

The health care legislation being considered by Congress seeks to reform Medicare and look for alternatives to the fee-for-service payment system, which critics say discourages care coordination and quality. American Medical News reports on one alternative called bundling, in which "doctors and hospitals are paid for all services to a patient in an episode of care for a particular condition.

4 Jan 2010

Cardiogenesis submits an IDE for its PHOENIX System

Cardiogenesis Corporation, today announced that it has submitted an IDE (Investigational Device Exemption) to the Food and Drug Administration to initiate a safety and feasibility trial for its PHOENIX System in patients with refractory angina. The PHOENIX handpiece is the first device specifically designed to allow physician-directed tissue stimulation and injections of biologic or pharmacologic agents to pre-determined areas of myocardium.

4 Jan 2010

Bausch & Lomb launches Crystalens AO intraocular lens

Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide.

4 Jan 2010

CDC aims for improved efficiency, increased support of science

Changes "aimed at increasing the agency's efficiency and making it more user-friendly" include combining "the work of the malaria branch, the epidemiology program and HIV/AIDS efforts" under the newly formed Center for Global Health, the Atlanta Journal-Constitution reports (Poole, 1/1).

4 Jan 2010

CBI signs definitive share purchase agreement to acquire GL Biochem

Commonwealth Biotechnologies, Inc. (“CBI”) is pleased to announced it has entered into a revised and binding definitive share purchase agreement to acquire the parent of Shanghai-based GL

4 Jan 2010

Obama administration focuses on data-driven results in health care

NPR reports the budget office's use of pedometers to encourage employees to do more physical activity exemplifies "the Obama administration [reliance] on intensive data-gathering to help mold behavior." Peter Orszag, director of the Office of Management and Budget, says "'[w]hen you measure something and have a competition surrounding it, it creates a strong incentive to do more of it.' … Whether it's health care, education or even the war in Afghanistan, the president and his team are big believers in the power of information."

4 Jan 2010

Sunlighten to unveil mPulse Series in April 2010

Sunlighten(TM) (www.sunlighten.com) is proud to unveil its mPulse(TM) Series, set to launch in April 2010, which is the world's first sauna with personalized biofeedback tracking as well as customizable full spectrum infrared heat that targets specific health concerns.

4 Jan 2010

FDA grants Priority Review designation for InterMune's NDA for pirfenidone

InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).

4 Jan 2010

Cepheid granted EUA for Xpert Flu A Panel test

Cepheid today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Xpert® Flu A Panel test.

4 Jan 2010

Amedisys completes acquisition of home health operations of Hackensack University Medical Center

Amedisys, Inc., one of America's leading home health nursing companies, today announced that it has received the regulatory approvals from the state of New Jersey and that it has completed the acquisition of the home health operations of Hackensack University Medical Center.

4 Jan 2010

GeckoSystems to resume in home personal companion robot trials after Holidays

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that they have resumed their in home personal companion robot trials for elder care after pausing during the Holidays.

4 Jan 2010

Dicerna Pharmaceuticals and Kyowa Hakko Kirin sign research collaboration and license agreement

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.

4 Jan 2010